Sermon Charles

CIK 00016873182 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001687318

Recent Transactions

13 trades

Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2026-02-01+315,750→ 315,750 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2026-02-01+295,000→ 295,000 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2026-02-01+105,250→ 105,250 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2025-01-25+262,000→ 262,000 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-09-13$4.22/sh−20,946→ 219,061 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-09-12$4.47/sh−9,980→ 240,007 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Performance Based Restricted Stock Unit
2024-09-11−65,600→ 0 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-09-11+65,600→ 249,987 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-26$3.39/sh−32,187→ 184,387 total
Sale
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-25$3.69/sh−14,202→ 216,574 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
Performance Based Restricted Stock Unit
2024-06-21+98,400→ 65,600 total
Exercise/Conversion
Mereo BioPharma Group plc$MREO
American Depositary Shares representing Ordinary Shares
2024-06-21+98,400→ 230,776 total
Award
Mereo BioPharma Group plc$MREO
Share Options (Right to buy)
2024-01-25+245,000→ 245,000 total

Companies

Recent Filings

Address

C/O MEREO BIOPHARMA GROUP PLC 4TH FLOOR, ONE CAVENDISH PLACE

LONDON, X0, W1G 0QF

View on SEC.gov